European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET).
appendiceal NET
follow-up
histopathological features
right hemicolectomy
vascular and lymphatic spread
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
31
07
2023
received:
18
07
2023
accepted:
01
08
2023
pubmed:
8
9
2023
medline:
8
9
2023
entrez:
8
9
2023
Statut:
ppublish
Résumé
The aim of the present guidance paper is to update the previous ENETS guidelines on well differentiated appendiceal neuroendocrine tumours (NET), providing practical guidance for the diagnosis and management of appendiceal NET (aNET); poorly differentiated neoplasms are dealt with in a separate guidance paper. This paper is structured on a question-answer format in order to also address controversial issues and areas where uncertainty regarding the management and follow-up of aNET exists. All recommendations are offered on the basis of the best available evidence, along with the authors' experiences in managing these neoplasms. Each recommendation for treatment will provide a level of evidence and grade of recommendation as per the GRADE system (adapted in Infectious Disease Society of United States Public Health Service grading system).
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13332Informations de copyright
© 2023 British Society for Neuroendocrinology.
Références
Guyatt GH, Oxman AD, Kunz R, et al. What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336(7651):995-998.
Toumpanakis C, Fazio N, Tiensuu Janson E, et al. Unmet needs in appendiceal neuroendocrine neoplasms. Neuroendocrinology. 2019;108(1):37-44.
Pape UF, Niederle B, Costa F, et al. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology. 2016;103(2):144-152.
Ribeiro S, De Maeyer F, De Man M, et al. Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015. Acta Gastroenterol Belg. 2021;84(3):458-466.
Holmager P, Willemoe GL, Nielsen K, et al. Neuroendocrine neoplasms of the appendix: characterization of 335 patients referred to the Copenhagen NET Center of Excellence. Eur J Surg Oncol. 2021;47(6):1357-1363.
Alabraba E, Pritchard DM, Griffin R, et al. The impact of lymph node metastases and right hemicolectomy on outcomes in appendiceal neuroendocrine tumours (aNETs). Eur J Surg Oncol. 2021;47(6):1332-1338.
Alexandraki KI, Kaltsas G, Grozinsky-Glasberg S, et al. The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN. Endocrine. 2020;70(1):178-186.
Brighi N, La Rosa S, Rossi G, et al. Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study. Ann Surg. 2020;271(3):527-533.
Daskalakis K, Alexandraki K, Kassi E, et al. The risk of lymph node metastases and their impact on survival in patients with appendiceal neuroendocrine neoplasms: a systematic review and meta-analysis of adult and paediatric patients. Endocrine. 2020;67(1):20-34.
Galanopoulos M, McFadyen R, Drami I, et al. Challenging the current risk factors of appendiceal neuroendocrine neoplasms: can they accurately predict local lymph nodal invasion? Results from a large case series. Neuroendocrinology. 2019;109(2):179-186.
Rault-Petit B, Do Cao C, Guyetant S, et al. Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a National study from the French Group of Endocrine Tumors (GTE). Ann Surg. 2019;270(1):165-171.
Pawa N, Clift AK, Osmani H, et al. Surgical management of patients with neuroendocrine neoplasms of the appendix: appendectomy or more. Neuroendocrinology. 2018;106(3):242-251.
Shibahara Y, Krzyzanowska M, Vajpeyi R. Appendiceal well-differentiated neuroendocrine tumors: a single-center experience and new insights into the effective use of immunohistochemistry. Int J Surg Pathol. 2022;31:252-259.
Couvelard A. Appendiceal neuroendcorine neoplasms. Digestive System Tumours WHO Classification of Tumours. 5th ed. WHO; 2019:152-155.
van Velthuysen MF, Couvelard A, Rindi G, et al. ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology. J Neuroendocrinol. 2022;34(3):e13100.
Perren A, Couvelard A, Scoazec JY, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology. 2017;105(3):196-200.
Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395-401.
Brierley J, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. John Wiley & Sons, Inc.; 2017.
Nesti C, Brautigam K, Benavent M, et al. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study. Lancet Oncol. 2023;24:187-194.
Mehrvarz Sarshekeh A, Advani S, Halperin DM, et al. Regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis. Oncotarget. 2017;8(59):99541-99551.
Mullen JT, Savarese DM. Carcinoid tumors of the appendix: a population-based study. J Surg Oncol. 2011;104(1):41-44.
Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB. Appendiceal neuroendocrine neoplasms: diagnosis and management. Endocr Relat Cancer. 2016;23(1):R27-R41.
Grozinsky-Glasberg S, Alexandraki KI, Barak D, et al. Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature. Neuroendocrinology. 2013;98(1):31-37.
Marotta V, Zatelli MC, Sciammarella C, et al. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocr Relat Cancer. 2018;25(1):R11-R29.
Modlin IM, Kidd M, Frilling A, et al. Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence with 94% accuracy. Ann Surg. 2021;274(3):481-490.
Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R. The mutational landscape of gastrointestinal malignancies as reflected by circulating tumor DNA. Mol Cancer Ther. 2018;17(1):297-305.
Chan DL, Hoang J, Roach PJ, et al. Routine early 68Ga-DOTATATE positron emission tomography has low yield after resection of appendiceal neuroendocrine neoplasms. Pancreas. 2020;49(7):891-896.
Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas. 2010;39(6):753-766.
de Mestier L, Lepage C, Baudin E, et al. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2020;52(5):473-492.
Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61(1):6-32.
NCCN. Guidelines Version2. 2016: Neuroendocrine Tumors of the Gastrointestinal Tract, Lung, and Thymus (Carcinoid Tumors). 2016.
Alexandraki KI, Griniatsos J, Bramis KI, et al. Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J Endocrinol Invest. 2011;34(4):255-259.
Ricci C, Ingaldi C, Alberici L, et al. Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis. Endocrine. 2019;66(3):460-466.
de Lambert G, Lardy H, Martelli H, Orbach D, Gauthier F, Guerin F. Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective French multicenter study of 114 cases. Pediatr Blood Cancer. 2016;63(4):598-603.
Njere I, Smith LL, Thurairasa D, et al. Systematic review and meta-analysis of appendiceal carcinoid tumors in children. Pediatr Blood Cancer. 2018;65(8):e27069.
In't Hof KH, van der Wal HC, Kazemier G, Lange JF. Carcinoid tumour of the appendix: an analysis of 1485 consecutive emergency appendectomies. J Gastrointest Surg. 2008;12(8):1436-1438.
Panek M, Szymczak M, Stepaniuk M, et al. Radical surgical treatment of neuroendocrine tumors of the appendix in children-a Polish multicenter study. Arch Med Sci. 2021;17(4):1128-1131.
Ranaweera C, Brar A, Somers GR, Sheikh F, Pierro A, Zani A. Management of pediatric appendiceal carcinoid: a single institution experience from 5000 appendectomies. Pediatr Surg Int. 2019;35(12):1427-1430.
Li MX, Lopez-Aguiar AG, Poultsides G, et al. Surgical treatment of neuroendocrine tumors of the terminal ileum or cecum: ileocecectomy versus right hemicolectomy. J Gastrointest Surg. 2022;26(6):1266-1274.
Munoz de Nova JL, Hernando J, Sampedro Nunez M, et al. Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. World J Gastroenterol. 2022;28(13):1304-1314.
Magdeburg J, Glatz N, Post S, Kienle P, Rickert A. Long-term functional outcome of colonic resections: how much does faecal impairment influence quality of life? Colorectal Dis. 2016;18(11):O405-O413.
Boxberger N, Redlich A, Boger C, et al. Neuroendocrine tumors of the appendix in children and adolescents. Pediatr Blood Cancer. 2013;60(1):65-70.
Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317(27):1699-1701.
Herrera-Martinez AD, Hofland LJ, Galvez Moreno MA, Castano JP, de Herder WW, Feelders RA. Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers. Endocr Relat Cancer. 2019;26(3):R157-R179.